SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001047469-11-002231
Filing Date
2011-03-16
Accepted
2011-03-16 17:09:11
Documents
6
Period of Report
2011-04-27
Effectiveness Date
2011-03-16

Document Format Files

Seq Description Document Type Size
1 DEF 14A a2202591zdef14a.htm DEF 14A 764506
2 G817752.JPG g817752.jpg GRAPHIC 6750
3 G979546.JPG g979546.jpg GRAPHIC 3974
4 G352051.JPG g352051.jpg GRAPHIC 6598
5 G25132BII001.GIF g25132bii001.gif GRAPHIC 101551
6 G25132BKI001.GIF g25132bki001.gif GRAPHIC 81835
  Complete submission text file 0001047469-11-002231.txt   1042884
Mailing Address 901 GATEWAY BLVD S. SAN FRANCISCO CA 94080
Business Address 901 GATEWAY BLVD SOUTH SAN FRANCISCO CA 94080 6508086000
THERAVANCE INC (Filer) CIK: 0001080014 (see all company filings)

IRS No.: 943265960 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 000-30319 | Film No.: 11692697
SIC: 2834 Pharmaceutical Preparations